Symbols / KLRA Stock $24.30 -3.65% Kailera Therapeutics, Inc.

Healthcare • Biotechnology • United States • NMS
KLRA (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: SMA 50: SMA 200:
About

No company description available for this symbol.

Fundamentals
Scroll to Statements
Market Cap 3.15B Enterprise Value Income -148.96M Sales Book/sh Cash/sh
Dividend Yield Payout 0.00% Employees 145 IPO P/E Forward P/E
PEG P/S P/B P/C EV/EBITDA EV/Sales
Quick Ratio 11.83 Current Ratio 12.02 Debt/Eq LT Debt/Eq EPS (ttm) -1.26 EPS next Y
EPS Growth Revenue Growth Earnings ROA -22.73% ROE -36.90% ROIC
Gross Margin 0.00% Oper. Margin 0.00% Profit Margin 0.00% Shs Outstand 129.54M Shs Float 9.71K Short Float
Short Ratio Short Interest 52W High 28.23 52W Low 23.65 Beta Avg Volume 3.43M
Volume 888.29K Target Price Recom None Prev Close $25.22 Price $24.30 Change -3.65%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
Mean price target
2. Current target
Latest analyst target
3. DCF / Fair value
$-8.32
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
Low
High
Mean

No recent news from Yahoo. Try the RSS feed for latest KLRA news.

Insider Transactions

No recent insider transactions.

Financials

No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.

SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category